Neuren Pharmaceuticals Limited (ASX:NEU)
Australia · Delayed Price · Currency is AUD
11.48
+0.08 (0.70%)
At close: Mar 18, 2026
Revenue by Segment
Financials in millions AUD. Fiscal year is January - December.
Millions AUD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
| 64.63M | 213.24M | 231.93M | 14.55M | - | | | | | |
Commercial Products Growth | -69.69% | -8.06% | 1493.66% | - | - | | | | | |
| 15.00K | 3.59M | 17.00K | - | - | | | | | |
| -99.58% | 21011.76% | - | - | - | | | | | |
| - | - | - | - | 3.20M | | | | | |
Pharmaceutical Products Growth | - | - | - | - | 345.89% | | | | | |
| 64.65M | 216.83M | 231.94M | 14.55M | 3.20M | | | | | |
| -70.18% | -6.51% | 1493.77% | 355.21% | 345.89% | | | | | |
Revenue by Geography
Financials in millions AUD. Fiscal year is January - December.
Millions AUD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
| 64.63M | 213.24M | - | - | - | | | | | |
| -69.69% | - | - | - | - | | | | | |
| 64.63M | 213.24M | - | - | - | | | | | |
| -69.69% | - | - | - | - | | | | | |
Source: S&P Global Market Intelligence.
